Feasibility Trial of CBT for Depersonalisation in Psychosis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02427542|
Recruitment Status : Completed
First Posted : April 28, 2015
Last Update Posted : August 8, 2016
|Condition or disease||Intervention/treatment||Phase|
|Psychotic Disorders Depersonalization||Other: CBT for Depersonalization/Derealization Other: Treatment as usual||Phase 1|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||20 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||Single (Outcomes Assessor)|
|Official Title:||A Brief Cognitive Behavioural Therapy (CBT) Intervention for Depersonalisation/Derealisation in Psychosis: a Feasibility Study|
|Study Start Date :||March 2015|
|Actual Primary Completion Date :||March 2016|
|Actual Study Completion Date :||March 2016|
Active Comparator: CBT for DP
Six sessions of CBT covering psycho-education, formulation, enhancing coping strategies (including grounding) and cognitive restructuring techniques.
Other: CBT for Depersonalization/Derealization
In addition to treatment as usual, six sessions of Cognitive Behavioural Therapy for Depersonalization/Derealisation covering psychoeducation, formulation, coping strategies.
Placebo Comparator: Treatment as usual
Participants will continue to receive their normal treatment - in most cases, this will be care coordination/case management delivered through a community mental health team and may include medication.
Other: Treatment as usual
Treatment as usual - in most cases case management/care coordination and may include medication
- Feasibility of intervention ( including recruitment rates, acceptance rates, drop outs) [ Time Frame: 10 weeks ]Feasibility estimates of delivering the intervention including recruitment rates, acceptance rates, drop outs.
- Depersonalisation score (Score on the Cambridge Depersonalisation Scale) [ Time Frame: 10 weeks ]Score on the Cambridge Depersonalisation Scale
- Acceptability of intervention (Satisfaction and attrition rates) [ Time Frame: 10 weeks ]Satisfaction and attrition rates
- Depression (Score on Beck Depression Inventory) [ Time Frame: 10 weeks ]Score on Beck Depression Inventory
- Anxiety (Score on Beck Anxiety Inventory) [ Time Frame: 10 weeks ]Score on Beck Anxiety Inventory
- Psychosis (Score on the Psychotic Symptom Rating Scale (PSYRATS) [ Time Frame: 10 weeks ]Score on the Psychotic Symptom Rating Scale (PSYRATS)
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02427542
|London, United Kingdom, SE5 8AZ|
|Principal Investigator:||Simone Farrelly, PhD||King's College London|